The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells

BACKGROUND: We previously demonstrated that a seminal plasma protein, semenogelin I (SgI), functioned as an androgen receptor (AR) coactivator. Meanwhile, several short sequence motifs in AR coregulators, such as LxxLL (L=leucine), have been shown to mediate specific interactions with AR. METHODS: W...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Cancer
Главные авторы: Li, Peng, Chen, Jinbo, Kashiwagi, Eiji, Mizushima, Taichi, Han, Bin, Inoue, Satoshi, Ide, Hiroki, Izumi, Koji, Miyamoto, Hiroshi
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2018
Предметы:
Molecular Diagnostics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808024/
https://ncbi.nlm.nih.gov/pubmed/29136406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.404
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы